NSE ScannerOpen the scanner

Comparison · NSE · data 2026-11-01

Balaxi Pharmaceuticals Limited vs QMS Medical Allied Services Limited

In plain words

Size: QMS Medical Allied Services Limited is about 3.3 times the market value of Balaxi Pharmaceuticals Limited.

Return on equity: QMS Medical Allied Services Limited 10.5% vs Balaxi Pharmaceuticals Limited 0.6%.

Profit growth over 3 years: QMS Medical Allied Services Limited 49.4% a year vs Balaxi Pharmaceuticals Limited -68.6% a year.

Debt to equity: QMS Medical Allied Services Limited 0.71 vs Balaxi Pharmaceuticals Limited 0.23.

Differences in the numbers, not a recommendation of either stock.

Side by side

BALAXIQMSMEDI
Price₹19.15₹181.17
Market cap₹106 cr₹350 cr
P/E—31.6
P/B——
ROE0.6%10.5%
ROCE—18.9%
Debt / equity0.230.71
Operating margin—12.7%
Dividend yield0.00%0.28%
Sales growth, 3 years (yearly)-7.0%49.3%
Profit growth, 3 years (yearly)-68.6%49.4%
1-year return-55.3%66.3%
Revenue, last 12 months—₹183 cr
Net profit, last 12 months—₹11 cr
Latest quarterJun 2026Jun 2026
Quarter net profit₹1 cr₹4 cr
Quarter profit vs a year earlier+348.3%-42.2%
Promoter holding65.99%68.11%
Health checkWeak (1.5/10)Strong (7.9/10)

Common questions

Which earns a higher return on equity?

QMS Medical Allied Services Limited (10.5% against 0.6%).

Which carries more debt?

QMS Medical Allied Services Limited has the higher debt-to-equity ratio (0.71 against 0.23).

BALAXI pageQMSMEDI page

Share on WhatsAppShare on Telegram